Nektar (NKTR) Shares Resume Trading Up 10%
Tweet
Share
E-mailGet Alerts NKTR Hot Sheet
Join SI Premium – FREE
Shares of Nektar (Nasdaq: NKTR) have resumed trading up about 10 percent upon resumption following news the company will sell the royalties for Cimzia and Mircera for $124 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- TD Cowen Assumes Nektar Therapeutics (NKTR) at Buy
- Bernstein sees 'an entry point in our top-pick' chemical stock
- Buy this stock to gain "growing AI/HPC exposure": Barclays
Create E-mail Alert Related Categories
Trading HaltsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
